COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment

• Michele Clerico,
• Irene Dogliotti,
• Andrea Calcagno,
• Daniele Grimaldi,
• Sarah Leone,
• Simone Ragaini,
• Massimo Boffini,
• Daniele Caracciolo,
• Simone Ferrero,
• Cristina Barbero,
• Elisa Zanotto,
• Giacomo Stroffolini,
• Rossana Cavallo,
• Mauro Rinaldi,
• Benedetto Bruno,
• Federica Cavallo

Affiliations

Michele Clerico

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Irene Dogliotti

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Andrea Calcagno

2 Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Ospedale Amedeo di Savoia, ASL TO2, Turin, Italy

Daniele Grimaldi

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Sarah Leone

3 Department of Internal Medicine, NYU Grossman School of Medicine, New York, USA

Simone Ragaini

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Massimo Boffini

4 Department of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Daniele Caracciolo

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Simone Ferrero

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Cristina Barbero

4 Department of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Elisa Zanotto

5 Unit of Microbiology and Virology, Department of Public Health and Pediatric Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Giacomo Stroffolini

2 Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Ospedale Amedeo di Savoia, ASL TO2, Turin, Italy

Rossana Cavallo

5 Unit of Microbiology and Virology, Department of Public Health and Pediatric Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Mauro Rinaldi

4 Department of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy

Benedetto Bruno

6 Division of Hematology and Medical Oncology, NYU Grossman School of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York, USA

Federica Cavallo

1 Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. “Città della Salute e della Scienza di Torino”, Turin, Italy